PTGS2 and Alzheimer disease: Moreover, in the same mouse model of AD, we also demonstrated that IV infused hAT-MSCs significantly reduced the disease severity through the suppression of B cell proliferation and maturation, and this effect was mediated by cyclooxygenase 2 (COX-2) signaling [66].